Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells

por Thijssen, Rachel, Alvarez-Diaz, Silvia, Grace, Clea, Gao, Ming-yuan, Segal, David H., Xu, Zhen, Strasser, Andreas, Huang, David C. S.
Publicado 2020